PathXL are specialists and innovators in the field of digital pathology. The company began as a spin-out from Queens University in Belfast, when digital pathology was very much in its early stages. The founders still maintain a close relationship with the pathology community.
These strong links, alongside the team’s technological expertise, has driven the company to where it is today.
As the digital pathology market continues to evolve, it is transforming entire workflows in education, research and clinical use. We intend to become known as the creative-thinkers and leaders in tumor analysis.
Viewed as global pioneers in the use of image analysis and workflow solutions for digital pathology, PathXL’s products are based around providing innovative software that can be used in education, research and clinical sectors worldwide.
As a web-based platform, PathXL can be installed locally on a customer site, or provided as a managed hosted service in the cloud, permitting clients to experience the value of remote digital pathology, without the overhead of managing their own platform or the need for major capital outlay.